蒂莫丁通过胸膜再生和T细胞功能重编程增强抗瘤免疫力
Md Amir Hossain1, Ye Zhang1, Li Ji2
1Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China.
Biomedicines
|October 29, 2025
概括
蒂莫丁 (TP5) 增强T细胞功能,逆转胸膜衰老,显著抑制小鼠的瘤生长. 这种可以通过增强T细胞免疫力和与采用细胞疗法的协同效应来改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在癌症免疫治疗中,T细胞功能障碍是关键的挑战,导致治疗耐药性.
- 像免疫检查点封锁和收养细胞转移这样的现有疗法都有局限性.
- 蒂莫丁 (TP5) 是一种免疫调节性,具有尚未探索的抗癌潜力.
研究的目的:
- 为了研究TP5.5的抗瘤疗效.
- 阐明TP5作用背后的免疫机制.
- 评估TP5作为基于T细胞的癌症治疗的辅助剂的潜力.
主要方法:
- 在黑色素瘤,结肠直肠癌和肝细胞癌的小鼠模型中测试了TP5的疗效.
- 使用流细胞计,ELISA和免疫光学分析了免疫细胞群和功能.
- 评估了TP5与采用T细胞疗法的协同效应.
主要成果:
- 在各种癌症模型中,TP5通过T细胞依赖机制显著抑制瘤生长.
- 即使在免疫受损的环境中,TP5也促进了胸腺复发,并恢复了外围T细胞免疫力.
- TP5保留了T细胞效应器功能,减少了疲劳,并增强了采用T细胞治疗的结果.
结论:
- TP5是一种强大的免疫调节剂,具有显著的抗癌活性.
- TP5解决了当前T细胞疗法的局限性,通过增强T细胞功能和打击胸膜内变.
- TP5显示出在癌症治疗中临床翻译的巨大潜力,特别是在组合疗法中.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


